Stock Alert: Enzo Biochem Shares Jump 28% In Early Trading

(RTTNews) - Shares of Enzo Biochem Inc. (ENZ) are rising over 28% in pre-market today, after the company announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo's ELISA platform, and a promising proprietary drug candidate (SK1-I).

The stock has been trading in the range of $1.56 - $4.85 for the past one year, and closed Wednesday's trade at $2.17, down 1 cent or 0.46%. ENZ is currently trading at $2.77, up 61 cents or 28.24% in the pre-market trading session.